Evidence map›Paper›PMID 30692543›Full record

ArticleNature communications2019

Venous identity requires BMP signalling through ALK3.

Alice Neal, Svanhild Nornes, Sophie Payne, Marsha D Wallace, Martin Fritzsche, Pakavarin Louphrasitthiphol, Robert N Wilkinson, Kira M Chouliaras, Ke Liu, Karen Plant and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Zebrafish in Cardiovascular Disease Research: from Model to Application.International journal of biological sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Transcription factors regulating vasculogenesis and angiogenesis.Developmental dynamics : an official publication of the American Association of Anatomists · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Alice NealLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Svanhild NornesLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Sophie PayneLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Marsha D WallaceLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Martin FritzscheLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Pakavarin LouphrasitthipholLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Robert N WilkinsonDepartment of Infection, Immunity and Cardiovascular Disease and Bateson Centre, University of Sheffield, Sheffield, S10 2TN, UK.
Kira M ChouliarasLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Ke LiuInstitute of Aging and Chronic Disease, University of Liverpool, Liverpool, L7 8TX, UK.
Karen PlantDepartment of Infection, Immunity and Cardiovascular Disease and Bateson Centre, University of Sheffield, Sheffield, S10 2TN, UK.
Radhika SholapurkarLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Indrika RatnayakaLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Wiebke HerzogUniversity of Muenster, Schlossplatz 2, Muenster, 48149, Germany.
Gareth BondLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Tim ChicoDepartment of Infection, Immunity and Cardiovascular Disease and Bateson Centre, University of Sheffield, Sheffield, S10 2TN, UK.
George Bou-GhariosInstitute of Aging and Chronic Disease, University of Liverpool, Liverpool, L7 8TX, UK.
Sarah De ValLudwig Institute for Cancer Research Ltd, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, UK. sarah.deval@dpag.ox.ac.uk.
Ludwig Cancer Research · GBUniversity of Oxford · GBUniversity of Sheffield · GBUniversity of Liverpool · GBUniversity of Münster · DE

Funding

British Heart Foundation FS/17/35/32929British Heart Foundation PG/13/2/29902British Heart Foundation PG/15/17/31332Medical Research Council MR/J007765/1Medical Research Council MR/P020941/1
6 · The paper itself

Abstract

Venous endothelial cells are molecularly and functionally distinct from their arterial counterparts. Although veins are often considered the default endothelial state, genetic manipulations can modulate both acquisition and loss of venous fate, suggesting that venous identity is the result of active transcriptional regulation. However, little is known about this process. Here we show that BMP signalling controls venous identity via the ALK3/BMPR1A receptor and SMAD1/SMAD5. Perturbations to TGF-β and BMP signalling in mice and zebrafish result in aberrant vein formation and loss of expression of the venous-specific gene Ephb4, with no effect on arterial identity. Analysis of a venous endothelium-specific enhancer for Ephb4 shows enriched binding of SMAD1/5 and a requirement for SMAD binding motifs. Further, our results demonstrate that BMP/SMAD-mediated Ephb4 expression requires the venous-enriched BMP type I receptor ALK3/BMPR1A. Together, our analysis demonstrates a requirement for BMP signalling in the establishment of Ephb4 expression and the venous vasculature.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsAnimals, Genetically ModifiedBone Morphogenetic Protein Receptors, Type IBone Morphogenetic ProteinsEndothelial CellsMice, KnockoutMice, TransgenicReceptor, EphB4Signal TransductionSmad1 ProteinSmad5 ProteinTransforming Growth Factor betaVeinsZebrafishZebrafish ProteinsBmpr1a protein, mouseBone Morphogenetic Protein Receptors, Type IBone Morphogenetic ProteinsReceptor, EphB4Smad1 ProteinSmad5 ProteinTransforming Growth Factor betaZebrafish Proteins

Identifiers

PMID30692543
PMCPMC6349860
OpenAlexW2913387229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.